Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health monitoring in resource-limited settings news

Show

From To
Issue Brief: Achieving undetectable: what questions remain in scaling-up HIV virologic treatment monitoring?

Although the majority of developing countries do not yet offer viral load testing on a routine basis, the use of HIV viral load monitoring is rapidly gathering pace in most developing countries. Which questions remain in further scaling up this gold standard for HIV treatment monitoring in these countries? Médecins Sans Frontières (MSF) is releasing Achieving Undetectable, the latest in a series of issue briefs and reports on access to viral load monitoring in resource-limited settings.

Published
15 December 2014
From
MSF
Sophisticated HIV diagnostics adapted for remote areas

Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.

Published
10 December 2014
From
Science Daily
Sophisticated HIV diagnostics adapted for remote areas

Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers funded by the National Institutes of Health have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.

Published
02 December 2014
From
National Institutes of Health
Landmark HIV diagnostic access program will save $150m and help achieve new global goals on HIV

Roche today announced a major Global Access Program to sharply lower the price of HIV viral load tests in low- and middle-income countries. This new initiative creates a ceiling price of US$ 9.40 per test, and will reduce Roche’s average price by more than 40% in low- and middle-income countries. When fully implemented, the Global Access Program is projected to save more than US$ 150 million in costs over the next five years.

Published
29 September 2014
From
UNAIDs press release
Roche launches Global Access Program for HIV viral load testing

To support the Global Access Program, Roche has committed to expanding access to its COBAS® AmpliPrep/COBAS TaqMan HIV-1 Test version 2.0 through a special pricing scheme for qualifying organizations in eligible countries.

Published
26 September 2014
From
Roche press release
Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas

A study by Massachusetts General Hospital investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine use of point-of-care CD4 testing at the time of HIV diagnosis would be cost effective in countries where health care and other resources are severely limited.

Published
17 September 2014
From
Eurekalert Inf Dis
UNAIDS and partners launch initiative to improve HIV diagnostics

The Joint United Nations Programme on HIV/AIDS (UNAIDS) has joined with global and regional partners to launch the Diagnostics Access Initiative which calls for improving laboratory capacity to ensure that all people living with HIV can be linked to effective, high-quality HIV treatment services.

Published
23 July 2014
From
UNAIDS
High prices hinder access to newer HIV drugs and optimal tests that ensure treatment is working

High prices continue to represent a major barrier to affordable access of both new HIV medicines and viral load testing -- which is the best way to monitor whether treatment is working -- according to two reports released today by international medical humanitarian organisation Médecins Sans Frontières (MSF).

Published
22 July 2014
From
MSF
Viral Load Testing Dismally Absent in Africa

As Africa scales up lifesaving antiretroviral therapy for HIV positive people, concerns are rife that the absence of mass routine viral load testing will hamper extending treatment to the millions who need it.

Published
20 May 2014
From
Inter Press Service
BD Launches New Point-of-Care System for HIV/AIDS Patients

Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings.

Published
28 April 2014
From
BD Biosciences press release

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.